Nanomedicines are a promising addition to the arsenal of new cancer therapies. During development, scientists must precisely track their distribution in the body, a task that can be severely limited by traditional 2D displays. With its stereoscopic capacity and real-time interactivity, virtual reality (VR) provides an encouraging platform to accurately visualize dynamic 3D volumetric data. In this research, we develop a prototype application to track nanomedicines in VR. This platform has the potential to enhance data assessment, comprehension and communication in preclinical research which may ultimately influence the paradigm of future clinical protocols.